A budget impact model for biosimilar infliximab in Crohn’s disease in Bulgaria, the Czech Republic, Hungary, Poland, Romania, and Slovakia
Brodszky, Valentin, Rencz, Fanni, Péntek, Márta, Baji, Petra, Lakatos, Péter L, Gulácsi, LászlóLanguage:
english
Journal:
Expert Review of Pharmacoeconomics & Outcomes Research
DOI:
10.1586/14737167.2015.1067142
Date:
July, 2015
File:
PDF, 290 KB
english, 2015